News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
323,521 Results
Type
Article (12395)
Company Profile (14)
Press Release (311107)
Multimedia
Podcasts (51)
Webinars (11)
Section
Business (86257)
Career Advice (574)
Deals (20502)
Drug Delivery (58)
Drug Development (42270)
Employer Resources (59)
FDA (8845)
Job Trends (7290)
News (160866)
Policy (16570)
Tag
Academia (839)
Accelerated approval (37)
Adcomms (13)
Allergies (107)
Alliances (19586)
ALS (95)
Alzheimer's disease (887)
Antibody-drug conjugate (ADC) (226)
Approvals (9191)
Artificial intelligence (328)
Autoimmune disease (152)
Automation (30)
Bankruptcy (183)
Best Places to Work (5985)
BIOSECURE Act (7)
Biosimilars (129)
Biotechnology (10)
Bladder cancer (129)
Brain cancer (38)
Breast cancer (417)
Cancer (3208)
Cardiovascular disease (278)
Career advice (518)
Career pathing (16)
CAR-T (127)
CDC (23)
Celiac Disease (1)
Cell therapy (418)
Cervical cancer (28)
Clinical research (38837)
Collaboration (977)
Compensation (355)
Complete response letters (51)
COVID-19 (1208)
CRISPR (50)
C-suite (498)
Cystic fibrosis (89)
Data (5179)
Decentralized trials (2)
Denatured (14)
Depression (102)
Dermatology (61)
Diabetes (311)
Diagnostics (3336)
Digital health (28)
Diversity (3)
Diversity, equity & inclusion (18)
Drug discovery (129)
Drug pricing (112)
Drug shortages (12)
Duchenne muscular dystrophy (171)
Earnings (45731)
Editorial (42)
Employer branding (3)
Employer resources (52)
Events (43473)
Executive appointments (495)
FDA (11202)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (702)
Gene editing (107)
Generative AI (29)
Gene therapy (369)
GLP-1 (489)
Government (2303)
Grass and pollen (4)
Guidances (359)
Healthcare (8326)
HIV (43)
Huntington's disease (27)
IgA nephropathy (70)
Immunology and inflammation (121)
Immuno-oncology (52)
Indications (136)
Infectious disease (1383)
Inflammatory bowel disease (123)
Inflation Reduction Act (5)
Influenza (79)
Intellectual property (191)
Interviews (68)
IPO (11438)
IRA (29)
Job creations (1579)
Job search strategy (454)
JPM (30)
Kidney cancer (11)
Labor market (52)
Layoffs (190)
Leadership (13)
Legal (3089)
Liver cancer (49)
Longevity (9)
Lung cancer (431)
Lymphoma (271)
Machine learning (25)
Management (22)
Manufacturing (548)
MASH (123)
Medical device (6855)
Medtech (6924)
Mergers & acquisitions (10013)
Metabolic disorders (784)
mRNA (74)
Multiple sclerosis (112)
NASH (10)
Neurodegenerative disease (168)
Neuropsychiatric disorders (54)
Neuroscience (1618)
NextGen: Class of 2026 (2375)
Non-profit (1158)
Now hiring (15)
Obesity (326)
Opinion (131)
Ovarian cancer (143)
Pain (132)
Pancreatic cancer (173)
Parkinson's disease (138)
Partnered (17)
Patents (382)
Patient recruitment (336)
Peanut (31)
People (23105)
Pharmaceutical (9)
Pharmacy benefit managers (23)
Phase 1 (10784)
Phase 2 (16633)
Phase 3 (14615)
Pipeline (6060)
Policy (210)
Postmarket research (1218)
Preclinical (4065)
Press Release (8)
Prostate cancer (189)
Psychedelics (33)
Radiopharmaceuticals (151)
Rare diseases (603)
Real estate (2541)
Recruiting (23)
Regulatory (14602)
Reports (24)
Research institute (750)
Resumes & cover letters (59)
Rett syndrome (33)
RNA editing (8)
RSV (40)
Schizophrenia (91)
Series A (92)
Series B (76)
Service/supplier (2)
Sickle cell disease (53)
Special edition (11)
Spinal muscular atrophy (84)
Sponsored (16)
Startups (1087)
State (1)
Stomach cancer (2)
Supply chain (71)
Tariffs (55)
The Weekly (37)
Vaccines (548)
Venture capital (56)
Weight loss (195)
Women's health (49)
Worklife (8)
Date
Last 7 days (376)
Last 30 days (1885)
Last 365 days (17028)
2026 (7263)
2025 (16931)
2024 (18753)
2023 (21728)
2022 (27432)
2021 (29347)
2020 (27473)
2019 (20270)
2018 (15392)
2017 (15930)
2016 (13384)
2015 (16760)
2014 (11831)
2013 (8925)
2012 (9971)
2011 (10438)
2010 (9363)
Location
Africa (295)
Alabama (27)
Alaska (2)
Arizona (126)
Arkansas (5)
Asia (20442)
Australia (2724)
California (7600)
Canada (2101)
China (726)
Colorado (267)
Connecticut (302)
Delaware (233)
Europe (48184)
Florida (1226)
Georgia (235)
Hawaii (1)
Idaho (15)
Illinois (494)
India (48)
Indiana (417)
Iowa (11)
Japan (321)
Kansas (81)
Kentucky (15)
Louisiana (12)
Maine (52)
Maryland (918)
Massachusetts (4770)
Michigan (156)
Minnesota (342)
Mississippi (4)
Missouri (70)
Montana (6)
Nebraska (13)
Nevada (95)
New Hampshire (45)
New Jersey (2234)
New Mexico (5)
New York (2072)
North Carolina (815)
North Dakota (2)
Northern California (3927)
Ohio (177)
Oklahoma (10)
Oregon (18)
Pennsylvania (1547)
Puerto Rico (14)
Rhode Island (20)
South America (480)
South Carolina (40)
South Dakota (1)
Southern California (3017)
Tennessee (86)
Texas (1043)
United States (25835)
Utah (231)
Vermont (1)
Virginia (186)
Washington D.C. (43)
Washington State (620)
West Virginia (2)
Wisconsin (46)
Wyoming (2)
323,521 Results for "european commission ec".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
April 29, 2026
·
8 min read
Press Releases
Norgine announces European Commission Marketing Authorisation for XOLREMDI® (mavorixafor), the first authorised treatment for patients with WHIM syndrome in the European Union
April 29, 2026
·
5 min read
Press Releases
Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults
April 28, 2026
·
8 min read
Press Releases
European Commission Approves Pfizer’s HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors
May 13, 2026
·
16 min read
Press Releases
Novartis Rhapsido® receives European Commission approval as first oral targeted treatment for chronic spontaneous urticaria
April 27, 2026
·
10 min read
Press Releases
Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy
April 28, 2026
·
7 min read
Press Releases
Rhythm Pharmaceuticals Announces IMCIVREE® (Setmelanotide) Granted Marketing Authorization by European Commission for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity
May 1, 2026
·
11 min read
Press Releases
Helsinn announces European Commission approval of AKYNZEO® Oral Suspension
February 18, 2026
·
2 min read
Press Releases
Moderna Receives European Commission Marketing Authorization for mCOMBRIAX, Moderna’s mRNA Combination Vaccine Against Influenza and COVID-19
April 21, 2026
·
6 min read
Press Releases
The European Commission (EC) Approves Bio-Thera Solutions’ BAT2206 (USYMRO®, ustekinumab), a biosimilar referencing Stelara®
August 27, 2025
·
5 min read
1 of 32,353
Next
